Multidisciplinary management of prostate cancer

The course is aimed at radiation oncologists, urologists, medical oncologists and other specialists and trainees who have a special interest in prostate cancer and are willing to update their knowledge.

Course director 

  • Jochen Walz, Urologist, Institut Paoli-Calmettes, Marseille (FR) 
  • Valérie Fonteyne, Radiation Oncologist, Ghent University Hospital, Ghent (BE)


  • Ferran Algaba, Pathologist, Autonomous University of Barcelona, Barcelona (ES) 
  • Alison Tree, Clinical Oncologist, The Royal Marsden NHS Foundation Trust, London (UK)
  • Nicolas Mottet, Urologist, University Hospital, Hopital Nord, Saint-Etienne (FR)
  • Alfonso Gomez de Iturriaga, Radiation Oncologist, Cruces University Hospital, Baracaldo (ES) 
  • Geert Villeirs, Radiologist, Ghent University Hospital, Ghent (BE) 
  • Markus Graefen, Medical Doctor, University Medical Center Hamburg-Eppendorf (DE)

Delineation administrator

  • Berardino de Bari, Radiation Oncologist, Hôpital Univ.Jean Minjoz, Besançon (FR)

This 4-day teaching course aims at focusing on the management of localised, locally advanced and metastatic prostate cancer. It emphasises the importance of a multidisciplinary approach and of teamwork, where full information exchange is vital to provide the best up-to-date scientific evidence on which the management of the disease will be based. This will be illustrated during state-of-the-art lectures presented by experts in the field, covering important issues such as biology, imaging, pathology, therapy and future developments. Interactive case studies and journal clubs will be integrated on a daily basis and there will be ample time for open discussions amongst participants and experts. A special session on target delineation for radiotherapists will also be organised during the course.


Learning outcomes

  • To provide an in-depth overview of the epidemiology, pathology, imaging and treatment options for low, intermediate and high risk prostate cancer 
  • To discuss patient selection/indications and contra-indications for the various treatment options
  • To provide a critical overview of the surgical and radiotherapy techniques available for the management of prostate cancer  
  • To discuss the new drugs currently available for the management of the advanced and metastatic stages of the disease
  • To debate on the most recent developments relevant to prostate cancer management.

Course content

  • Normal prostate: anatomy – embryology, histology
  • Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities pathology, staging
  • Low risk prostate cancer: active surveillance, surgery and the postop pathology
  • Radiotherapy and brachytherapy, the pathology after irradiation
  • External beam radiotherapy: on-line control, target delineation
  • High risk prostate cancer: radiotherapy and hormones, alternative radiotherapy regimens
  • Toxicity of radiotherapy: acute and late morbidity – erectile dysfunction
  • Role of surgery and its morbidity
  • Alternative treatments
  • Adjuvant and salvage radiotherapy after radical surgery
  • Rising PSA after surgery and after radiotherapy
  • Imaging for recurrent detection
  • Node positive prostate cancer
  • Metastatic prostate cancer: hormones and their complications
  • Castration resistant prostate cancer: new drugs
  • Palliative radiotherapy and surgery
  • Non systemic treatment in the metastatic setting.
  • Case Discussions


Before commencing this course participants should:  

  • Revise the general principles of prostate cancer epidemiology, pathology, diagnosis and staging
  • Read the published ESTRO and ASTRO guidelines on prostate contouring and the EAU/ESTRO/SIOG/EANM/ESUR guidelines on prostate cancer
  • Complete the FALCON* exercise which is distributed prior to the course.

Teaching methods

  • 21 hours lectures
  • 3 hours contouring
  • 4 hours practical workshops
  • 5 hours interactive discussions.

The course consists of didactic lectures, interactive sessions (clinical case discussions and Journal Clubs) and practical demonstrations.

Methods of assessment

  • In-class voting
  • Delineation exercise  



The scientific programme is available here

Further reading / Web resources

To be provided if available.


Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.


ESTRO members can order products at substantially reduced prices. Please note that in order to benefit from the member price, you must renew your membership for 2021 before registering to the course.To benefit from these member rates, please visit the membership page to become a member or renew your membership BEFORE proceeding with your order.



Online Standard

Online Desk








Multidisciplinary Prostate

€ 350.00

 € 400.00

 € 500.00

 € 600.00

 € 600.00

 €  600.00

Brachy Prostate

€ 350.00

 € 400.00

 € 500.00

 € 600.00

 € 600.00

 €  600.00

Combined Fee

€ 550.00

 € 700.00

 € 850.00

 € 700.00

 € 800.00

 €  900.00

*Only avilable to members

If you want to benefit from a discount by registering for both Multidisciplinary Management of Prostate Cancer and Brachytherapy for Prostate Cancer please send a mail to:

Insurance and cancellation

Access to homework and/or course material will become available upon receipt of full payment.

The organiser does not accept liability for individual medical, travel or personal insurance. Participants are strongly advised to take out their own personal insurance policies.   

In case an unforeseen event would force ESTRO to cancel the meeting, the Society will reimburse the participants fully the registration fees. ESTRO will not be responsible for the refund of travel and accommodation costs.

In case of cancellation, full refund of the registration fee minus 15% for administrative costs may be obtained up to three months before the course and 50% of the fee up to one month before the course. No refund will be made if the cancellation request is postmarked less than one month before the start of the course.

Reduced fees

ESTRO members from economically challenged countries may register at a preferential rate of 350 Euro if three conditions are met:

  1. Only ESTRO members for 2021 are eligible (please make sure your 2021 membership is in order before you apply for the reduced fees)
  2. Only one course per person per year can be subsidized by ESTRO
  3. Sponsored candidates are not entitled to reduced fees (the invoicing address has to be the one of the participant)  

Please note:

  • We can only guarantee a certain number of reduced fees per course
  • Application deadlines are the same as early registration fees (3 months before the course date).


If you want to benefit from a discount by registering for both Multidisciplinary Management of Prostate Cancer and Brachytherapy for Prostate Cancer please send a mail to: